Search Results - "BERK, Veli"

Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology–oncology patients by Demiraslan, Hayati, Sevim, Mustafa, Pala, Çiğdem, Durmaz, Süleyman, Berk, Veli, Kaynar, Leylagül, Metan, Gökhan

“…Stenotrophomonas maltophilia infection is of concern in patients with cancer. Antibiotics active against S. maltophilia are rarely used in the treatment of…”
Get full text

Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients by Duran, Ayse Ocak, Inanc, Mevlude, Karaca, Halit, Dogan, Imran, Berk, Veli, Bozkurt, Oktay, Ozaslan, Ersin, Ucar, Mahmut, Eroglu, Celalettin, Ozkan, Metin

“…Prior studies showed a relationship between serum albumin and the albumin to globulin ratio with different types of cancer. We aimed to evaluate the predictive…”
Get full text

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer by Inanc, Mevlude, Ozkan, Metin, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Duran, Ayse Ocak, Ozaslan, Ersin, Akgun, Hulya, Tekelioglu, Fatos, Elmali, Ferhan

“…In subgroups of breast cancer, the shortest disease-free and overall survival was observed in basaloid and human epidermal growth factor receptor-2 groups…”
Get full text

Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer by Mutlu, Hasan, Berk, Veli, Karaca, Halit, Erden, Abdülsamet, Aslan, Tuncay, Akca, Zeki

“…The risk of thromboemboli is increased in patients with cancer, and this is precipitated by the chemotherapeutic agents. Bevacizumab is an anti-vascular…”
Get more information

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology by Berk, Veli, Kaplan, Mehmet Ali, Tonyali, Onder, Buyukberber, Suleyman, Balakan, Ozan, Ozkan, Metin, Demirci, Umut, Ozturk, Turkan, Bilici, Ahmet, Tastekin, Didem, Ozdemir, Nuriye, Unal, Olcun Umit, Oflazoglu, Utku, Turkmen, Esma, Erdogan, Bulent, Uyeturk, Ummugul, Oksuzoglu, Berna, Cinkir, Havva Yesil, Yasar, Nurgul, Gumus, Mahmut

“…Inoperable and metastatic hepatocellular carcinoma (HCC) is associated with a poor prognosis and low chemotherapeutic efficiency. Sorafenib is an oral…”
Get full text

Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer by Bozkurt, Oktay, Inanc, Mevlude, Turkmen, Esma, Karaca, Halit, Berk, Veli, Duran, Ayse Ocak, Ozaslan, Ersin, Ucar, Mahmut, Hacibekiroglu, Ilhan, Eker, Baki, Baspinar, Osman, Ozkan, Metin

“…To investigate clinicopathological features in patients with recurrent colorectal cancer within 1 year and more than 1 year after curative resection. We…”
Get full text

Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? by Bozkurt, Oktay, Hacıbekiroglu, Ilhan, Kaplan, Muhammet Ali, Duzkopru, Yakup, Uysal, Mukremin, Karaca, Halit, Berk, Veli, Inanc, Mevlude, Duran, Ayse Ocak, Ozaslan, Ersin, Ucar, Mahmut, Ozkan, Metin

“…Micro-Abstract Although there has been an increase in overall and progression-free survival with the use of novel targeted therapies in metastatic renal cell…”
Get full text

Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor by Cetin, Bulent, Kaplan, Mehmet Ali, Berk, Veli, Tufan, Gulnihal, Benekli, Mustafa, Isikdogan, Abdurrahman, Ozkan, Metin, Coskun, Ugur, Buyukberber, Suleyman

“…Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns…”
Get full text

Salvage Chemotherapy with Weekly Paclitaxel for Metastatic Melanoma by Ozaslan, Ersin, Aksoy, Asude, Gumusay, Ozge, Arpaci, Erkan, Berk, Veli

Get full text

Analyses of Multiple Factors for Determination of "Selected Patients" Who Should Receive Rechallenge Treatment in Metastatic Colorectal Cancer: a Retrospective Study from Turkey by Ozaslan, Ersin, Duran, Ayse Ocak, Bozkurt, Oktay, Inanc, Mevlude, Ucar, Mahmut, Berk, Veli, Karaca, Halit, Elmali, Ferhan, Ozkan, Metin

“…Background: Repeating a prior chemotherapy (rechallenge therapy) is an option for selected patients with metastatic colorectal cancer, but there is very little…”
Get full text

Are Rogerofenib and Nilotinib Effective for Advanced Gastrointestinal Stromal Tumor (GIST) Patients who have Already been Given Main Treatments? by Ozaslan, Ersin, Ozkan, Metin, Bozkurt, Oktay, Duran, Ayse Ocak, Ucar, Mahmut, Eker, Baki, Berk, Veli, Karaca, Halit

Get full text

Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients by Eker, Baki, Ozaslan, Ersin, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Inanc, Mevlude, Duran, Ayse Ocak, Ozkan, Metin

“…Background: Colorectal cancer (CRC) is a major cause of mortality in developed countries, and it is the third most frequent malignancy in Turkey. There are…”
Get full text

Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab by Berk, Veli, Deniz, Kemal, Bozkurt, Oktay, Ozaslan, Ersin, Karaca, Halit, Inanc, Mevlude, Duran, Ayse Ocak, Ozkan, Metin

“…Background: There is no suggested molecular indicator for the determination of which patients will benefit from anti-angiogenetic treatment in metastatic…”
Get full text

Haematologic Parameters in Metastatic Colorectal Cancer Patients Treated with Capecitabine Combination Therapy by Inanc, Mevlude, Duran, Ayse Ocak, Karaca, Halit, Berk, Veli, Bozkurt, Oktay, Ozaslan, Ersin, Ozkan, Metin

“…Background: The standard treatment in the metastatic colorectal cancer consists of 5-FU based infusional regimens. However, with oral fluoropyrimidines, equal…”
Get full text

Association of Human Epidermal Growth Factor Receptor-2 Expression and Clinicopathological Findings in Patients with Colorectal Cancer by Karaca, Halit, Deniz, Kemal, Berk, Veli, Inanc, Mevlude, Ozkan, Metin

“…Background: To determine the frequency of HER-2 overexpression in colorectal cancer (CRC) patients, and to explore the relationship between clinicopathological…”
Get full text

Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer by Yazilitas, Dogan, Sendur, Mehmet Ali Nahit, Karaca, Halit, Ozdemir, Nuriye, Aksoy, Sercan, Berk, Veli, Yazici, Ozan, Ozturk, Banu, Ozkan, Metin, Zengin, Nurullah, Altundag, Kadri

“…Background: Adding taxanes to adjuvant antracycline and cyclophosphamide (AC) in combination may provide significant improvement in node-positive and high risk…”
Get full text

Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer by Bozkurt, Oktay, Berk, Veli, Kaplan, Muhammed Ali, Cetin, Bulent, Ozaslan, Ersin, Karaca, Halit, Inanc, Mevlude, Duran, Ayse Ocak, Ozkan, Metin

“…Background: Capecitabine is an oral fluoropyrimidine derivative which is frequently used alone or in combination regimens for the treatment of metastatic…”
Get full text

Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in GEP-NETs by Berk, Veli, Ozaslan, Ersin

“…Abstract only…”
Get full text

Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy by Karaca, Halit, Bozkurt, Oktay, Ozaslan, Ersin, Baldane, Suleyman, Berk, Veli, Inanc, Mevlude, Duran, Ayse Ocak, Dikilitas, Mustafa, Er, Ozlem, Ozkan, Metin

“…The present study aimed to determine the effect of oral ${\beta}$-glucan on mucositis and leukopenia in 62 consecutive patients with colorectal cancer treated…”
Get full text

Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer by Bozkurt, Oktay, Inanc, Mevlude, Turkmen, Esma, Karaca, Halit, Berk, Veli, Duran, Ayse Ocak, Ozaslan, Ersin, Ucar, Mahmut, Hacibekiroglu, Ilhan, Eker, Baki, Baspinar, Osman, Ozkan, Metin

“…Purpose: To investigate clinicopathological features in patients with recurrent colorectal cancer within 1 year and more than 1 year after curative resection…”
Get full text